Arcus Biosciences, Inc.

RCUS · Healthcare · Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States

Arcus Biosciences, Inc. (RCUS), in the Healthcare sector, has 18 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 0 purchases and 18 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jul 10 and filed Jul 13. The most active filer was Juan C. Jaen with 7 filings.

Add to watchlist

Filings, ttm

0 buys · 18 sells

Traders, ttm

6 insiders

Volume, ttmiDollar value disclosed in the window

$13.6M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jul 10

Filed Jul 13

ADViAverage daily dollar volume

$38.5M

market data

Share price · 12M

$29.36 (+134.5%)

Adjusted for splits and dividends.

Volume by month

Buys $15.4M Sells $13.6M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Juan C. Jaen President 7 filings IG

II Robert C. Goeltz Chief Financial Officer 5 filings JJ

Jennifer Jarrett Chief Operating Officer 3 filings TR

Terry J Rosen Chief Executive Officer 2 filings GI Gilead Sciences, Inc. 10% owner 1 filing YK

Yasunori Kaneko Director 1 filing RM

Richard Markus Chief Medical Officer 1 filing CT

Carolyn C. Tang General Counsel 1 filing

Recent filings

Juan C. JaenSALE President $2.0M
68,301 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 5:36 PM ET Juan C. JaenSALE President $830K
29,734 sh across 3 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET II Robert C. GoeltzSALE Chief Financial Officer $199K
7,763 sh × $25.63
Exec May 11
Filed May 12 · 5:30 PM ET Juan C. JaenSALE President $633K
29,670 sh × $21.34
Exec Jan 5
Filed Jan 7 · 5:30 PM ET II Robert C. GoeltzSALE Chief Financial Officer $153K
6,552 sh × $23.38
Exec Dec 31 2025
Filed Jan 2 · 5:30 PM ET Terry J RosenSALE Chief Executive Officer $1.2M
54,691 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET Juan C. JaenSALE President $467K
21,208 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET Jennifer JarrettSALE Chief Operating Officer $467K
21,208 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET II Robert C. GoeltzSALE Chief Financial Officer $279K
12,662 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET Richard MarkusSALE Chief Medical Officer $111K
5,052 sh × $21.88
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET Carolyn C. TangSALE General Counsel $318K
14,468 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET Juan C. JaenSALE President $2.1M
82,997 sh × $24.71
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET II Robert C. GoeltzSALE Chief Financial Officer $125K
5,000 sh × $25.00
Exec Nov 26 2025
Filed Nov 26 2025 · 5:30 PM ET Juan C. JaenSALE President $913K
44,950 sh across 2 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET Jennifer JarrettSALE Chief Operating Officer $954K
50,291 sh × $18.97
Exec Nov 7 2025
Filed Nov 12 2025 · 5:30 PM ET Juan C. JaenSALE President $2.0M
96,059 sh across 3 lots
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET II Robert C. GoeltzSALE Chief Financial Officer $100K
5,000 sh × $20.00
Exec Oct 28 2025
Filed Oct 29 2025 · 5:30 PM ET Jennifer JarrettSALE Chief Operating Officer $751K
50,292 sh across 2 lots
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET Terry J RosenPURCHASE Chief Executive Officer $202K
19,800 sh × $10.18
Exec Feb 27 2025
Filed Feb 27 2025 · 5:30 PM ET Yasunori KanekoPURCHASE Director $201K
20,000 sh × $10.06
Exec Feb 27 2025
Filed Feb 27 2025 · 5:30 PM ET Gilead Sciences, Inc.PURCHASE 10% owner $15.0M
1,363,636 sh × $11.00
Exec Feb 18 2025
Filed Feb 20 2025 · 5:30 PM ET